Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0104-2021

Drug recall · December 2, 2020

clomiPRAMINE Hydrochloride Capsules USP recall

Why: Failed Tablet/Capsule Specification

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30

Lots / codes

Lot# 20P0141, exp. date 02/2022

Quantity
4,416 bottles
Company
Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
Distribution
Product was distributed nationwide.
Initiated
November 6, 2020 · Voluntary: Firm initiated
Classified
November 24, 2020
Reported
December 2, 2020
Ended
March 23, 2022
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Clomipramine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.